Bits of technology from I.B.M.’s Watson are beginning to be used in actual products available to corporate clients. The cloud-based Strategic Intellectual Property Insight Platform “uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical journals to look for chemical compounds used in drug discovery.” As a byproduct of this project, I.B.M. is contributing their research to the searchable NIH chemical database, which will ease access to information previously mired in paperwork.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
TagsBIO EVENT Plant biotechnology Biotechnology Industry biotech industry FDA biotechnology patent business development Benefits of biotech crops healthcare BIO Investor Forum Sustainability BIO agriculture health Health Care Food Intellectual Property BIOTECH global food crisis
- Most Popular
- ALS Awareness Month: 10 Things You Should Know About ALS
- The Real Reason Why Salk Refused to Patent the Polio Vaccine
- Psoriasis Awareness Month: Psoriasis isn’t contagious but awareness is!
- Biotech CEOs Speak Out on JOBS Act Success
- Stopped at the Threshold: A New Study Reports on PTO Patent Examinations in the wake of Mayo and Myriad
Latest VideoChristophe Ramstein, Novasentis Inc. at the 2014 BIO International Convention View All >